Bovine Brucellosis Control of indirect ELISA kits

Similar documents
COMMISSION REGULATION (EC)

COMMISSION REGULATION (EU)

European Porcine Brucellosis Standard Serum (EUPBSS) ielisa (pig ielisa) validation Ring-Trial

Official Journal of the European Union L 8/29

OIE Reference Laboratory Reports Activities

(Text with EEA relevance) (2014/798/EU)

Adopted by CVMP 10 March Date for coming into effect 1 July Revised draft guideline agreed by Immunologicals Working Party 22 June 2017

Council of the European Union Brussels, 14 February 2017 (OR. en)

COMMISSION IMPLEMENTING REGULATION (EU)

Council of the European Union Brussels, 6 February 2017 (OR. en)

COMMISSION DELEGATED REGULATION (EU).../... of XXX

COMMISSION REGULATION (EU) / of XXX

DECISIONS. (Text with EEA relevance) (2014/199/EU)

Draft Agreed by Immunologicals Working Party January Adoption by CVMP for release for consultation 12 March 2009

COMMISSION REGULATION (EU) / of XXX

Working Document prepared by the Commission services - does not prejudice the Commission's final decision 3/2/2014 COMMISSION STAFF WORKING DOCUMENT

A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

DRAFT COMMISSION DELEGATED REGULATION (EU) /... of XXX

DIRECTIVES. (Text with EEA relevance)

COMMISSION REGULATION (EU) / of XXX

IVD information *Droppers for the sensitized and control cells. Not for use other than dispensing the sensitized and control cells.

Official Journal of the European Union L 109/11

To detect antibodies to Avian Influenza (AI) using the haemagglutination inhibition test in avian serum specimens 2.

Procedural advice on the submission of variations for annual update of human influenza inactivated vaccines applications in the centralised procedure

Regulation of FMD vaccines within the European Union

Validation report. First commercially-available ELISA which allows for the detection of Lumpy Skin Disease antibodies

COMMISSION DELEGATED REGULATION (EU) /... of XXX

Official Journal of the European Union. (Non-legislative acts) REGULATIONS

Bovine Insulin ELISA

Influenza A IgG ELISA

L 256/32 Official Journal of the European Union

Delegations will find attached document D042445/02.

Official Journal of the European Union

COMMISSION IMPLEMENTING DECISION. of

COMMISSION DELEGATED REGULATION (EU) /... of XXX

SCIENTIFIC DISCUSSION

H.Pylori IgG

OIE Reference Laboratory Reports Activities

H.Pylori IgG Cat # 1503Z

COMMISSION IMPLEMENTING DECISION. of XXX

(Text with EEA relevance)

Official Journal of the European Union REGULATIONS

DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004

Procine sphingomyelin ELISA Kit

SERION ELISA classic CMV Avidity Reagent B109 AVID

COMMISSION DELEGATED REGULATION (EU) /... of XXX

Toxoplasma gondii IgM (Toxo IgM)

H. pylori Antigen ELISA Kit

Rat C-peptide ELISA. For the quantitative determination of C-peptide in rat serum

H. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

EURL ECVAM TEMPLATE FOR CLASSIFICATION OF CHEMICALS FOR SERIOUS EYE DAMAGE / EYE IRRITATION FROM IN VIVO DRAIZE EYE TEST DATA Explanatory document

COMMISSION REGULATION (EU) / of XXX

COMMISSION DIRECTIVE 97/48/ EC. of 29 July 1997

COMMISSION REGULATION (EC)

Hyaluronan Quantification Kit

Herpes Simplex Virus 2 IgM HSV 2 IgM

ACCESS TO EC MARKET REQUIREMENTS TO FACILITIES BLATERAL NEGOTIATIONS ON ISSUES OF SANITARY AND PHYTO-SANITARY MEASURES

EU REFERENCE LABORATORIES FOR AVIAN INFLUENZA AND NEWCASTLE DISEASE

COMMISSION REGULATION (EU)

Delegations will find attached document D051559/03.

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

Feed Additive Approval An Industry View. Dr Heidi Burrows Regulatory manager

Rat Insulin ELISA. For the quantitative determination of insulin in rat serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures.

Guideline on influenza vaccines submission and procedural requirements

Guidance Document. Importing Semen & Embryos. 10 August 2017

Import Health Standard. For. Bovine Embryos

Vedolizumab Drug Level ELISA

GUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE

Council of the European Union Brussels, 30 January 2018 (OR. en) Mr Jeppe TRANHOLM-MIKKELSEN, Secretary-General of the Council of the European Union

COMMISSION IMPLEMENTING DECISION. of

SURVEILLANCE, PREVENTION, AND DISEASE MANAGEMENT OF AVIAN INFLUENZA IN THE EUROPEAN UNION 1

Council of the European Union Brussels, 24 March 2015 (OR. en)

Toxoplasma gondii IgM ELISA Kit

Herpes Simplex Virus 2 IgG HSV 2 IgG

This Administrative regulation will come into force on 1 st January 2018 and will remain so until further notice. Administrative Regulation No 3/2015

Official Journal of the European Communities COMMISSION

Official Journal of the European Union. (Non-legislative acts) REGULATIONS

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) GUIDELINE ON USER SAFETY FOR IMMUNOLOGICAL VETERINARY MEDICINAL PRODUCTS

See external label 96 tests HSV 2 IgA. Cat #

L 108/2 Official Journal of the European Union (8) Potassium chromate meets the criteria for classification as carcinogenic and mutagenic Re

HIV-1 p24 ELISA Kit. purified polyclonal antibody raised against the full length recombinant p24 is used.

Mouse C-peptide ELISA

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

Official Journal of the European Union REGULATIONS

Legal basis for LSD within and outside EU Session 1: Contingency planning, risk management and communication

OIE Reference Laboratory Reports Activities

LSD: Vaccine Quality

Structure of the EU Regulation for Organic Farming

Council of the European Union Brussels, 12 November 2015 (OR. en)

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Unit G5 - Veterinary Programmes

Mouse C-peptide ELISA

Official Journal of the European Union

Mouse HBsAg(Hepatitis B Virus Surface Antigen) ELISA Kit

European Union legislation on Food additives, Food enzymes, Extractions solvents and Food flavourings

Transcription:

Bovine Brucellosis Control of indirect ELISA kits (Individual serum samples & pooled serum samples) Standard Operating Procedure Control of Bovine brucellosis Serum ELISA kits SOP Page 1 / 7 02 February 2012

SAFETY PRECAUTIONS The laboratory shall take all precautions in order to guarantee the necessary safety, for both the operator and the environment, against the biological and chemical hazards due to the activities conducted according to this document. 1 Scope The present document describes a standard technique aiming at controlling the fulfilment of OIE and EU requirements regarding the standardisation of indirect enzyme-linked immunosorbent assays (I- ELISA) kits for the detection of antibodies specific to smooth Brucella species (especially B. abortus, B. melitensis and B. suis) in bovine individual sera or pools of sera. 2 Normative references Bovine brucellosis, In: The OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (mammals, birds and bees), 2011, Chapter 2.4.3., OIE, Paris, online version adopted by the World Assembly of Delegates of the OIE in May 2009. http://www.oie.int/fileadmin/home/eng/health_standards/tahm/2.04.03_bovine_brucell.pdf Commission Decision of 10 December 2008 amending Annex C to Council Directive 64/432/EEC and Decision 2004/226/EC as regards diagnostic tests for bovine brucellosis (notified under document number C(2008) 7642) (Text with EEA relevance) (2008/984/EC), Official Journal of the European Union 31.12.2008, L 352/38-45. ISO/IEC 17025, General requirements for the competence of testing and calibration laboratories. OIE Quality Standard and Guidelines for Veterinary Laboratories, 2 nd Edition, 2008, OIE, Paris. 3 Definitions Bovine brucellosis Infection of bovines due to bacteria of the genus Brucella, naturally in the smooth (S) phase (B. abortus, B. melitensis or B. suis), pathogenic for most mammal species, in which this infection usually induces the production of S-Brucella-specific antibodies. National Reference Laboratory for Brucellosis (NRL) Laboratory officially designated as such by the authority of the corresponding Member State. According to the abovementioned Commission Decision, this NRL is responsible for: (1) the approval of the results of the validation studies demonstrating the reliability of the test method used in the Member State; (2) determination of the maximum number of samples to be pooled in ELISA kits used; (3) calibration of working standards /.../; (4) quality checks of all antigens and ELISA kits batches used in the Member State; (5) following recommendations of, and cooperating with the EU reference laboratory for brucellosis. Control of Bovine brucellosis Serum ELISA kits SOP Page 2 / 7 02 February 2012

Official Control Laboratory (OCL) Laboratory in charge of the official control of all antigens and ELISA kits batches used in the Member State (usually the Members State s NRL). This activity could be assigned to another laboratory, the NRL of another Member State, in particular. International standard sera International standard sera for Bovine brucellosis enzyme-linked immunosorbent assays (ELISAs) are 1 : o the weak positive OIE ELISA standard serum (OIEELISA WP SS); o the strong positive OIE ELISA standard serum (OIEELISA SP SS); o the negative OIE ELISA standard serum (OIEELISA N S). The required limit of detection is the 1/16 dilution of the OIEELISA SP SS or the 1/2 dilution of the OIEELISA WP SS, made up in negative serum. Dilutions 1/64 for the OIEELISA SP SS or 1/8 for the OIEELISA WP SS must be found negative. Secondary or National standard serum Secondary or national standard serum established against the abovementioned OIE standard sera and containing a defined concentration of anti-brucella antibody corresponding to a defined activity in bovine brucellosis serum ELISAs. Dilution Initial pre-dilution of the serum made up in a dilution negative serum (7.5) before further appropriate dilution in the dilution buffer of the kit subject to control. Dilutions are made directly (no serial dilutions) and with an initial volume of neat serum of at least 10 µl. A minimum volume of 10 µl of the dilution is used to perform the final dilution in the dilution buffer of the kit subject to control. 4 Specific requirements before submission of a kit to control Nil. 5 Sampling The supplier or manufacturer sends the complete kits (microplates, reagents, final packaging, and instructions for use) to the OCL in sufficient quantity for the performance of all tests needed by the present procedure (initial control and/or control of a new batch, control of a batch during the validity period). 1 Obtainable from the OIE Reference Laboratory for Brucellosis at AHVLA Weybridge, Addlestone, Surrey KT15 3NB, UK. Due to the limited stock left, the OIEISS should be restricted to the control of conventional antigens (RBT, CFT, SAT, MRT in particular) and must not be used for the control of ELISA kits. Control of Bovine brucellosis Serum ELISA kits SOP Page 3 / 7 02 February 2012

6 Storage and disposal of batch samples According to the instructions of the supplier/manufacturer during the validity period. 7 Standard sera and Reference materials These materials are stored at a temperature < -16 C or freeze-dried and stored at 5 C ± 3 C. 7.1 International standard sera (OIEELISA WP SS or OIEELISA SP SS and OIEELISA N SS) 7.2 Secondary or national standard sera (at least the positive standard) 7.3 Reference panel of positive sera Bovine serum samples issued from animals naturally or experimentally infected by smooth Brucella (B. abortus, B. melitensis or B. suis). These sera must be chosen in such a way that the reaction obtained is slightly above the cut-off. 7.4 Reference panel of negative sera Bovine serum samples issued from brucellosis free animals. Some of these sera may present characteristics known as interfering with the reaction (background for instance). 7.5 Dilution Negative serum (DNS) A pool of at least 3 negative bovine serum samples is recommended. 7.6 Reference serum for the measure of repeatability Dilution of a bovine positive serum made up in the DNS (7.5) in such a manner that it shows a titre comparable or just above the required level of detection. Note: materials 7.2-7.6 must be made available to any kit supplier/manufacturer on request. 8 Principle 8.1 Initial Control This control is performed on the first batch of a new ELISA kit, submitted to the OCL for approval, once the validation dossier has been submitted by the supplier/manufacturer to the NRL and has been approved by the latter as fulfilling the OIE requirements 2. The OCL is to check the following parameters: 2 Chapter 1.1.4/5. Principles and methods of validation of diagnostic assays for infectious diseases. Online version adopted in May 2009. http://www.oie.int/fileadmin/home/eng/health_standards/tahm/1.1.04_valid.pdf Control of Bovine brucellosis Serum ELISA kits SOP Page 4 / 7 02 February 2012

8.1.1 Limit of detection (LOD) 8.1.1.1 ELISA kits for individual sera: - dilutions at 1/8, 1/16, 1/32 and 1/64 of the OIEELISA SP SS or, - dilutions at 1/1, 1/2, 1/4 and 1/8 of the OIEELISA WP SS or, - appropriate equivalent dilutions of the national or secondary bovine brucellosis standard serum (7.2), tested twice per plate in two plates. 8.1.1.2 ELISA kits for pools of X sera: - dilutions identical to the abovementioned dilutions, but further diluted in DNS (7.5) at 1/X and tested twice per plate in two plates. 8.1.2 Sensitivity 8.1.2.1 ELISA kits for individual sera: - Five positive sera from the Reference panel of positive sera (7.3) tested twice per plate in two plates. 8.1.2.2 ELISA kits for pools of X sera: - Five positive sera from the Reference panel of positive sera (7.3) diluted 1/X in DNS (7.5) and tested twice per plate in two plates. 8.1.3 Specificity 8.1.3.1 ELISA kits for individual sera: - Five negative sera from the Reference panel of negative sera (7.4) tested twice per plate in two plates. 8.1.3.2 ELISA kits for pools of X sera: - Five negative sera from the Reference panel of negative sera (7.4) diluted 1/X in DNS (7.5) and tested twice per plate in two plates. 8.1.4 Repeatability Reference serum for the measure of repeatability (7.6) tested at least 20 times per plate in two plates; the same preparation of the serum dilution is distributed in each well with the same mono-channel pipette for all the wells used. 8.2 Control of a new batch This control is performed by the OCL on samples of any new batch to be approved in the corresponding Member State and is identical to the initial control described above (8.1) 8.3 Control of a batch during the validity period This control is performed by the OCL in the middle of the validity period of the product. The OCL may decide not to perform this control, if the supplier/manufacturer provides the results of a corresponding internal control. Control of Bovine brucellosis Serum ELISA kits SOP Page 5 / 7 02 February 2012

Otherwise, the OCL can decide to perform this control, if needed, especially according to information from the routine diagnostic laboratories. The following parameters are checked: - LOD - Sensitivity - Specificity -Repeatability 9 Equipment and plastic/glass ware Conventional serology laboratory equipment. 10 Operating procedure The OCL must follow the instructions for use of the respective kit. Nevertheless, the positive and negative control sera of the kit may be tested in the plates more times than those prescribed in the instructions for use of the corresponding kit. The OCL can decide to use the minimal or the maximal values of time and temperature ranges prescribed by the instructions for use. The initial control and the control of a new batch are performed at least in two plates. The control during the validity period is performed at least in one plate. 11 Interpretation of results The criteria for the interpretation of results are identical for the initial control, the control of a new batch and the control during the validity period. 11.1 LOD - a 1/2 dilution of the OIEELISA WP SS or a 1/16 pre-dilution of the OIEELISA SP SS made up in DNS must give a positive reaction; - a 1/8 dilution of the OIEELISA WP SS or a 1/64 pre-dilution of the OIEELISA SP SS made up in DNS must give a negative reaction. 11.2 Sensitivity All five positive sera from the Reference panel of positive sera (7.3) must give a positive reaction. 11.3 Specificity All five negative sera from the Reference panel of negative sera (7.3) must give a negative reaction. Control of Bovine brucellosis Serum ELISA kits SOP Page 6 / 7 02 February 2012

11.4 Repeatability The CV of the OD values obtained for the 20 repeats of the test of the Reference serum for the measure of repeatability (7.6) must be less than (or equal to) 10 % in each plate. 12 Restitution of results The OCL provides the supplier/manufacturer with the detailed results corresponding to the tests described in chapter 8, and, in particular, the OD values obtained and the template followed for the different plates. 13 Analysis report The analysis report must comply with the requirements of ISO/IEC 17025. The report clearly mentions whether the kit complies or not with the acceptability criteria. Control of Bovine brucellosis Serum ELISA kits SOP Page 7 / 7 02 February 2012